Cystic fibrosis infection study halted early

NCT ID NCT03312075

Terminated Knowledge-focused Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aimed to find out how common non-tuberculous mycobacteria (NTM) infections are in people with cystic fibrosis in France. Researchers collected sputum and blood samples from 848 participants to test for NTM using culture and a new blood test. The study was terminated early, so results may be limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cystic fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CYSTIC FIBROSIS

Contacts and locations

Show contact details

Locations

AP-HP Hôpital Cochin

Paris, 75679, France
AP-HP Hôpital Foch

Suresnes, 92151, France
CHIC Créteil

Créteil, 94000, France
CHR Sud Réunion

Saint-Pierre, 97410, France
CHRU Brest

Brest, 29200, France
CHU Amiens

Amiens, Amiens, 80054, France
CHU Bordeaux

Pessac, 33604, France
CHU Côte de Nacre

Caen, 14033, France
CHU Grenoble

Grenoble, 38043, France
CHU Lille

Lille, 59037, France
CHU Rouen

Rouen, 76031, France
CHU Toulouse

Toulouse, 31059, France
CHU Tours

Tours, 37044, France
Centre de Perharidy

Roscoff, 29684, France